Merck & Co Inc (NYSE:MRK)
| 83.09 BATS BZX Real-Time Price As of 11:19am ET |  -0.10 / -0.12%Today’s Change | 65.25 Today|||52-Week Range 90.97 | +1.58% Year-to-Date |
Latest MRK News | Press Releases
| Why Gilead Sciences Stock Is Jumping Today Jan 19 / MotleyFool.com - Paid Partner Content | Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals Jan 15 / Zacks.com - Paid Partner Content |
| Biohaven (BHVN) Falls as Troriluzole Fails in Alzheimer's Study Jan 19 / Zacks.com - Paid Partner Content | Merck (MRK) Stock Moves -0.21%: What You Should Know Jan 14 / Zacks.com - Paid Partner Content |
| AstraZeneca's (AZN) Enhertu Gets FDA Nod for Gastric Cancer Jan 19 / Zacks.com - Paid Partner Content | Esperion (ESPR) Reports Q4 Preliminary Results, Stock Down Jan 14 / Zacks.com - Paid Partner Content |
| AstraZeneca (AZN) Gets EU Nod for Improved Imfinzi Dosing Jan 18 / Zacks.com - Paid Partner Content | Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA Jan 13 / Zacks.com - Paid Partner Content |
| Pfizer's (PFE) Xalkori Gets FDA Nod for Rare Lymphoma in Kids Jan 15 / Zacks.com - Paid Partner Content | 3 Coronavirus Stocks to Stay Miles Away From in 2021 Jan 12 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 83.19 |
| Today’s open | 83.48 |
| Day’s range | 82.78 - 83.56 |
| Volume | 1,627,143 |
| Average volume (3 months) | 8,702,310 |
| Market cap | $211.0B |
Data as of 11:19am ET, 01/20/2021
Growth & Valuation
| Earnings growth (last year) | +64.36% |
| Earnings growth (this year) | +15.73% |
| Earnings growth (next 5 years) | +8.80% |
| Revenue growth (last year) | +9.75% |
| P/E ratio | 18.4 |
| Price/Sales | 5.04 |
| Price/Book | 8.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.15 | -0.41% |
| NVSNovartis | -0.01 | -0.01% |
| ABBVAbbVie | +0.37 | +0.33% |
| LLYEli Lilly and Co | +1.56 | +0.79% |
Data as of 11:19am ET, 01/20/2021
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $1.38 |
| Annual revenue (last year) | $46.6B |
| Annual profit (last year) | $9.8B |
| Net profit margin | 21.13% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
